US Patent Issued to Ascensia Diabetes Care Holdings on Jan. 20 for "Detecting reinsertion of a continuous glucose monitoring sensor" (New York Inventor)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,527,497, issued on Jan. 20, was assigned to Ascensia Diabetes Care Holdings AG (Basel, Switzerland).

"Detecting reinsertion of a continuous glucose monitoring sensor" was invented by Anthony P. Russo (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "A continuous glucose monitoring (CGM) system is configured to detect a reinserted CGM sensor. The system reads a CGM sensor identifier stored in a CGM sensor unit memory in response to insertion of a CGM sensor into the skin of user. The system compares the identifier to any previously-stored identifiers of previously-inserted CGM sensors. If the identifier does not match a previously-stored identifie...